Small Intestine Transplantation

Intestinal transplantation is a surgical procedure performed for patients with severe intestinal failure in whom the small intestine can no longer adequately absorb nutrients and fluids.

It is typically considered for patients who:

• Depend on long-term parenteral nutrition (intravenous nutrition)
• Develop serious complications related to parenteral nutrition
• Experience loss of reliable central venous access
• Have congenital mucosal disorders
• Have tumors involving the origin of major intestinal blood vessels
• Have irreversible short bowel syndrome or other causes of intestinal failure
  
  

The goal of intestinal transplantation is to restore enteral nutrition, eliminate dependence on parenteral nutrition, and improve long-term survival and quality of life.

Both deceased donor and living donor transplantation may be performed. In living donor transplantation, a portion of the donor’s small intestine is transplanted. In deceased donor transplantation, either the entire small intestine or a segment may be transplanted depending on the recipient’s size and clinical needs.

Pre-Transplant Evaluation

A comprehensive medical evaluation is required to determine transplant eligibility and surgical safety. This may include:

• Blood testing (blood type, tissue compatibility, viral screening)
• Chest imaging and electrocardiogram
• Echocardiography
• Vascular imaging
• Gastrointestinal evaluation
• Assessment for infection sources (including dental evaluation)
• Evaluation of liver function (especially in long-term parenteral nutrition patients)
• Psychosocial and nutritional assessment
  
  

The purpose of this evaluation is to assess overall organ function and identify factors that may affect postoperative recovery.

Preoperative Preparation

Prior to surgery:

• Informed consent is obtained after detailed discussion.
• Patients are instructed to fast before surgery.
• Intravenous access is established for fluid and medication administration.
• Preventive measures against infection are implemented.
• Anticoagulation and thrombosis prevention strategies may be initiated.
• Patients practice deep breathing exercises to reduce postoperative pulmonary complications.
  
  

Intestinal preparation may be performed to reduce bacterial load prior to surgery.

During Surgery

Intestinal transplantation is performed under general anesthesia.

The procedure involves:

1. Removal of the diseased segment of small intestine.
2. Implantation of the donor intestine.
3. Connection of the donor intestine’s blood vessels to the recipient’s circulation.
4. Restoration of gastrointestinal continuity.
   
   

In some cases, the patient’s native intestine may be partially preserved. The surgical duration varies depending on the complexity of the case.

Immediate Postoperative Care

After surgery:

• The patient is transferred to the intensive care unit for close monitoring.
• Hemodynamic stability and graft perfusion are carefully observed.
• Immunosuppressive therapy is initiated immediately.
• Frequent laboratory tests are performed to monitor organ function and medication levels.
  
  

Supportive devices may include:

• Nasogastric tube to decompress the gastrointestinal tract
• Abdominal drains
• Urinary catheter for accurate urine output monitoring
  
  

Pain control is provided, often using patient-controlled analgesia.

Early Recovery Phase

• Gradual reintroduction of enteral feeding begins as intestinal function recovers.
• Parenteral nutrition may continue temporarily.
• Breathing exercises and early mobilization are encouraged to prevent pulmonary complications.
• Blood tests and imaging studies are performed regularly to detect early signs of rejection or infection.

Early Complications

• Bleeding
• Infection
• Vascular thrombosis
• Anastomotic leak
• Delayed graft function
• Acute rejection
  
  

Intestinal transplantation carries a higher risk of rejection compared to some other solid organ transplants due to the immune activity of intestinal tissue.

Long-Term Complications

• Chronic rejection
• Graft failure
• Recurrent infection
• Liver dysfunction (especially in patients previously dependent on parenteral nutrition)
• Complications related to long-term immunosuppressive therapy
  
  

Careful monitoring of immunosuppressive drug levels is essential to balance rejection prevention and infection risk.

Successful intestinal transplantation may allow discontinuation of long-term parenteral nutrition and restoration of oral or enteral feeding.

Early Post-Discharge Monitoring

After discharge:

• Frequent outpatient follow-up is required, especially during the first three months.
• Blood tests monitor organ function, electrolytes, and immunosuppressant levels.
• Imaging and endoscopic evaluations may be performed to assess graft health.
• Nutritional status is closely monitored.
  
  
  

Long-Term Management

• Lifelong immunosuppressive therapy is required.
• Regular laboratory testing and clinical evaluation continue indefinitely.
• Nutritional counseling supports adaptation to enteral feeding.
• Infection prevention strategies remain important due to immunosuppression.
  
  

Gradual increase in physical activity is encouraged as strength improves.

With careful patient selection and close postoperative management, intestinal transplantation can significantly improve nutritional autonomy and quality of life in patients with intestinal failure.